Galapagos is planning to wind down its cell therapy business, completing a whiplash change that saw the biotech go from focusing on the modality to ditching it in six months. Belgium-based Galapagos ...

Investing.com -- Galapagos stock fell 15% after the biotechnology company announced it would wind down its cell therapy business following unsuccessful attempts to find a buyer for the unit. The ...

From left, Tammie Muise, director of the clinical learning and simulation centre, and Catherine O’Brien, a standardized patient with the centre, spoke with Island Morning host Mitch Cormier during CBC ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

Galapagos (NASDAQ:GLPG) ADRs dropped ~13% in the premarket on Tuesday after the Belgian biotech announced plans to wind down its cell therapy business, impacting roughly 365 employees in Europe, the U ...

Galapagos NV is winding down its cell and gene therapy (CGT) division after an unsuccessful attempt to sell the unit, becoming the latest biotech to retreat from a sector that has lost momentum after ...

*Deposit Taken* Discover the epitome of coastal living in this exquisitely designed, oversized studio apartment with stunning water views. Perfectly positioned just minutes' walk to the iconic Bronte ...

Assassin's Creed franchise boss Marc-Alexis Côté has departed Ubisoft after a career spanning more than 20 years, IGN understands. The news comes just two weeks after Assassin's Creed, Ubisoft's ...